FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases
Cyltezo is first interchangeable monoclonal antibody for RA, psoriatic arthritis, ankylosing spondylitis, Crohn disease, ulcerative colitis, chronic plaque psoriasis
More Than Half of COVID-19 Survivors Have Postacute Sequelae
Most common sequelae include functional mobility impairments, pulmonary abnormalities, and mental health disorders
Taxane-Containing Chemo Associated With Persistent Alopecia
However, many patients experience improvements in hair density with standard alopecia treatments
Pharmacies Often Not Notified of Discontinued Rx
Interventions, including phoning pharmacies and enabling CancelRX in electronic medical records, may reduce risk for medication safety events
FDA Takes New Action to Improve Quality, Efficacy of Sunscreens
Proposed changes include updates to safe active ingredients and broad spectrum requirements
Live Attenuated Zoster Vaccine Safe for Patients Receiving TNF Inhibitors
No cases of varicella infection found; cumulative incidence of varicella infection or shingles was 0 percent
Vaccines Effective in Preventing Symptomatic COVID-19 in Health Care Workers
Findings seen even for those at risk for severe disease and racial and ethnic groups disproportionately affected by the pandemic
Overall Cancer Incidence, Mortality Lower for U.S. Hispanics
But rates higher for infection-related cancers, such as liver and stomach cancers, and cervical cancer
Incidence of Psoriatic Arthritis Up With More Severe Psoriasis
Incidence of psoriatic arthritis increases with increasing severity of psoriasis stratified by treatment severity surrogates
Precedent Needed for FDA Approval Decisions When Evidence Lacking
In seven of 22 cases, approval used new interpretations of original evidence and did not require new evidence
